Asthma and autoimmunity: A complex but intriguing relation

Expert Review of Clinical Immunology

Volumn 4, Issue 6, 2008, Pages 767-776

  Tedeschi, Alberto ^a   Asero, Riccardo ^b  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b Clinica San Carlo   (Italy)

Author keywords

Asthma; Autoantibody; Autoimmunity; Nonallergic asthma

Indexed keywords

ALLERGEN; AUTOANTIBODY; AUTOANTIGEN; EPITHELIAL MEMBRANE ANTIGEN; IMMUNOGLOBULIN E; NEUTROPHIL CYTOPLASMIC ANTIBODY; VASOACTIVE AGENT;

ALLERGIC ASTHMA; ASTHMA; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BRONCHUS MUCOSA; CHRONIC INFLAMMATION; DISEASE ASSOCIATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; RESPIRATORY TRACT INFLAMMATION; REVIEW; SKIN MANIFESTATION;

EID: 67149097280     PISSN: 1744666X     EISSN: None     Source Type: Journal    
DOI: 10.1586/1744666X.4.6.767     Document Type: Review

References (91)

1. Stene LC, Nafstad P. Relation between occurrence of Type 1 diabetes and asthma. Lancet 357(9256), 607-608 (2001
2. Tedeschi A, Airaghi L. Common risk factors in Type 1 diabetes and asthma. Lancet 357(9268), 1622 (2001
3. Bach JF. The effect of infections on susceptibility to autoimmune and allergic diseases. N. Engl. J. Med. 347(12), 911-920 (2002
4. Zweiman B. Asthma and autoimmunity: is there a connection? Curr. Allergy Asthma Rep. 7(3), 157-158 (2007
5. Rackeman FM. A working classification of asthma. Am. J. Med. 3, 601-606 (1947
6. Humbert M, Menz G, Ying S et al. The immunopathology of extrinsic (atopic) and intrinsic (non-atopic) asthma: more similarities than differences. Immunol. Today 20(11), 528-533 (1999
7. Humbert M, Durham SR, Ying S et al. IL-4 and IL-5 mRNA and protein in bronchial biopsies from patients with atopic and non atopic asthma: evidence against 'intrinsic' asthma being a distinct immunopathological entity. Am. J. Respir. Crit. Care Med. 154(5), 1497-1504 (1996
8. Kay AB. Allergy and allergic diseases. First of two parts. N. Engl. J. Med. 344(1), 30-37 (2001
9. Kay AB. Allergy and allergic diseases. Second of two parts. N. Engl. J. Med. 344(2), 109-113 (2001
10. Burrows B, Martinez FD, Halonen M, Barbee RA, Cline MG. Association of asthma with serum IgE levels and skin test reactivity to allergens. N. Engl. J. Med. 320 (5), 271-277 (1989
11. Beeh KM, Ksoll M, Buhl R. Elevation of total serum immunoglobulin E is associated with asthma in nonallergic individuals. Eur. Respir. J. 16(4), 609-614 (2000
12. Ying S, Humbert M, Meng Q et al. Local expression of e germline gene transcripts and RNA for the e heavy chain of IgE in the bronchial mucosa in atopic and nonatopic asthma. J. Allergy Clin. Immunol. 107(4), 686-692 (2001
13. Takhar P, Corrigan CJ, Smurthwaite L et al. Class switch recombination to IgE in the bronchial mucosa of atopic and nonatopic patients with asthma. J. Allergy Clin. Immunol. 119(1), 213-218 (2007
14. Romanet-Manent S, Charpin D, Magnan A, Lanteaume A, Vervloet D; The EGEA Cooperative Group. Allergic vs nonallergic asthma: what makes the differences? Allergy 57(7), 607-613 (2002
15. Robinson DS, Hamid Q, Ying S et al. Predominant Th2-like bronchoalveolar T-lymphocyte population in atopic asthma. N. Engl. J. Med. 326(5), 298-304 (1992
16. Walker C, Bode E, Boer L, Hansel TT, Blaser K, Virchow JC. Allergic and nonallergic asthmatics have distinct patterns of T-cell activation and cytokine production in peripheral blood and bronchoalveolar lavage. Am. Rev. Respir. Dis. 146(1), 109-115 (1992
17. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. Lancet 351(9111), 1225-1232 (1998
18. EURODIAB ACE Study Group. Variation and trends in incidence of childhood diabetes in Europe. Lancet 355(9207), 873-876 (2000
19. Karvonen M, Viik-Kajander M, Moltchanova E, Libman I, La Porte R, Tuomilehto J. Incidence of childhood Type 1 diabetes worldwide. Diabetes Mondiale (DiaMond) Project Group. Diabetes Care 23(10), 1516-1526 (2000
20. Simpson CR, Anderson WJA, Helms PJ et al. Coincidence of immune-mediated diseases driven by Th1 and Th2 subsets suggests a common aetiology. A population-based study using computerized general practice data. Clin. Exp. Allergy 32(1), 37-42 (2002
21. Tedeschi A, Airaghi L. Is affluence a risk factor for bronchial asthma and Type 1 diabetes? Pediatr. Allergy Immunol. 17(7), 533-537 (2006
22. Kurtzke JF. Multiple sclerosis in time and space - geographical clues to cause. J. Neurovirol. 6(Suppl. 2), S134-S140 (2000
23. Hernán MA, Olek MJ, Ascherio A. Geographic variation of MS incidence in two prospective studies of US women. Neurology 53(8), 1711-1718 (1999
24. Sonnenberg A, McCarty DJ, Jacobsen SJ. Geographic variation of inflammatory bowel disease within the United States. Gastroenterology 100(1), 143-149 (1991
25. Strachan DP. Hay fever, hygiene, and household size. BMJ 299, 1259-1260 (1989
26. Holt PG, Sly PD, Björksten B. Atopic versus infectious diseases in childhood: a question of balance? Pediatr. Allergy Immunol. 8, 53-58 (1997
27. Romagnani S. The increased prevalence of allergy and the hygiene hypothesis: missing immune deviation, reduced immune suppression, or both? Immunology 112, 352-363 (2004
28. Chatila TA. Role of regulatory T cells in human diseases. J. Allergy Clin. Immunol. 116, 949-959 (2005
29. Caffarelli C, Cavagni G, Pierdomenico R, Chiari G, Spattini A, Vanelli M. Coexistence of IgE-mediated allergy and Type 1 diabetes in childhood. Int. Arch. Allergy Immunol. 134(4), 288-294 (2004
30. Tirosh A, Mandel D, Mimouni FB, Zimlichman E, Shochat T, Kochba I. Autoimmune diseases in asthma. Ann. Intern. Med. 144(12), 877-883 (2006
31. Kero J, Gissler M, Hemminki E, Isolauri E. Could Th1 and Th2 diseases coexist? Evaluation of asthma incidence in children with celiac disease, Type 1 diabetes, or rheumatoid arthritis: a register study. J. Allergy Clin. Immunol. 108(5), 781-783 (2001
32. Sheikh A, Smeeth L, Hubbard R. There is no evidence of an inverse relationship between Th2-mediated atopy and Th1-mediated autoimmune disorders: lack of support for the hygiene hypothesis. J. Allergy Clin. Immunol. 111(1), 131-135 (2003
33. Potena A, La Corte R, Fabbri LM, Papi A, Trotta F, Ciaccia A. Increased bronchial responsiveness in primary and secondary Sjögren's syndrome. Eur. Respir. J. 3(5), 548-553 (1990
34. Hassan WU, Keaney NP, Hollan CD, Kelly CA. Bronchial reactivity and airflow obstruction in rheumatoid arthritis. Ann. Rheum. Dis. 53(8), 511-514 (1994
35. La Corte R, Bajocchi G, Potena A, Govoni M, Trotta F. Bronchial hyperreactivity in systemic sclerosis patients: influence of associated Sjögren's syndrome. Ann. Rheum. Dis. 54(8), 636-639 (1995
36. Amin K, Lúdvíksdóttir D, Janson C et al.; BHR-Group. Bronchial hyper-responsiveness. Inflammation and structural changes in the airways of patients with primary Sjögren's syndrome. Respir. Med. 95(11), 904-910 (2001
37. Jayaratnam A, Corrigan CJ, Lee TH. The continuing enigma of non-atopic asthma. Clin. Exp. Allergy 35(7), 835-837 (2005
38. Bachert C, Gevaert P, van Cauwenberge P. Staphylococcus aureus enterotoxins: a key in airway disease? Allergy 57(6), 480-487 (2002
39. Welliver RC, Wong DT, Sun M, Middleton E Jr, Vaughan RS, Ogra PL. The development of respiratory syncytial virus-specific IgE and the release of histamine in nasopharyngeal secretions after infection. N. Engl. J. Med. 305(15), 841-846 (1981
40. Busse WW. Respiratory infections: their role in airway responsiveness and the pathogenesis of asthma. J. Allergy Clin. Immunol. 85(4), 671-683 (1990
41. Ten Brinke A, van Dissel JT, Sterk PJ, Zwinderman AH, Rabe KF, Bel EH. Persistent airflow limitation in adultonset nonatopic asthma is associated with serologic evidence of Chlamydia pneumoniae infection. J. Allergy Clin. Immunol. 107(3), 449-454 (2001
42. Pasternack R, Huhtala H, Karjalainen J. Chlamydophila (Chlamydia) pneumoniae serology and asthma in adults: a longitudinal analysis. J. Allergy Clin. Immunol. 116(5), 1123-1128 (2005
43. Venter JC, Fraser CM, Harrison LC. Autoantibodies to ?2-adrenergic receptors: a possible cause of adrenergic hyporesponsiveness in allergic rhinitis and asthma. Science 207(4437), 1361-1363 (1980
44. Leopold HC, Rynes S, Stoloff IL. Fluorescent antibody study for antinuclear antibodies in bronchial asthma. J. Allergy Clin. Immunol. 36, 175-177 (1965
45. Leopold HC, Leicht P. Autoimmune antibodies to human lung in bronchial asthma. Ann. Allergy 27(8), 377-383 (1969
46. Lidor Y, Topilsky M, Spitzer SA, Yeoshua H. Autoimmune antibodies in intrinsic (non-atopic) asthma. Ann. Allergy 44(5), 296-298 (1980
47. Szczeklik A, Nizankowska E, Serafin A, Dyczek A, Duplaga M, Musial J. Autoimmune phenomena in bronchial asthma with special reference to aspirin intolerance. Am. J. Respir. Crit. Care Med. 152(6 Pt 1), 1753-1756 (1995
48. Comi AL, Tedeschi A, Lorini M, Miadonna A. Novel clinical and serological aspects in non-allergic asthma. Respir. Med. 101(12), 2526-2533 (2007
49. Nahm DH, Shin MJ, Yim H et al. Increased levels of circulating autoantibodies to cultured human bronchial epithelial cell in adult patients with nonatopic asthma. J. Korean Med. Sci. 16, 407-410 (2001
50. Nahm DH, Lee YE, Yim EJ et al. Identification of cytokeratin-18 as a bronchial epithelial autoantigen associated with nonallergic asthma. Am. J. Respir. Crit. Care Med. 165(11), 1536-1539 (2002
51. Nahm DH, Lee KH, Shin JY, Ye YM, Kang Y, Park HS. Identification of ?-enolase as an autoantigen associated with severe asthma. J. Allergy Clin. Immunol. 118(2), 376-381 (2006
52. Lassalle P, Delneste Y, Gosset P, Gras-Masse H, Wallaert B, Tonnel AB. T and B cell immune response to a 55-kDa endothelial cell-derived antigen in severe asthma. Eur. J. Immunol. 23(4), 796-803 (1993
53. Lassalle P, Joseph M, Ramn P, Dracon M, Tonnel AB, Capron A. Plasmapheresis in a patient with severe asthma associated with auto-antibodies to platelets. Clin. Exp. Allergy 20(6), 707-712 (1990
54. Inganäs M, Johansson SG, Bennich H. Anti-IgE antibodies in human serum: occurrence and specificity. Int. Arch. Allergy Appl. Immunol. 65(1), 51-61 (1981
55. Bünder R, Mittermann I, Herz Un et al. Induction of autoallergy with an environmental allergen mimicking a self protein in a murine model of experimental allergic asthma. J. Allergy Clin. Immunol. 114(2), 422-428 (2004
56. Garn H, Mittermann I, Valenta R, Renz H. Autosensitization as a pathomechanism in asthma. Ann. NY Acad. Sci. 1107, 417-425 (2007
57. Greaves MW. Chronic urticaria. J. Allergy Clin. Immunol. 105(4), 664-672 (2000
58. Grattan CE, Wallington TB, Warin RP, Kennedy CT, Bradfield JW. A serological marker in chronic idiopathic urticaria - a clinical, immunological and histological evaluation. Br. J. Dermatol. 114(5), 583-590 (1986
59. Hide M, Francis DM, Grattan CEH, Hakimi J, Kochan JP, Greaves MW. Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria. N. Engl. J. Med. 328(22), 1599-1604 (1993
60. Tedeschi A, Comi A L, Lorini M, Tosini C, Miadonna A. Autologous serum skin test reactivity in patients with non-allergic asthma. Clin. Exp. Allergy 35(7), 849-853 (2005
61. Asero R, Tedeschi A, Riboldi P, Cugno M. Plasma of chronic urticaria patients show signs of thrombin generation and its intradermal injection causes wheal-andflare reactions much more frequently than autologous serum. J. Allergy Clin. Immunol. 117(5), 1113-1117 (2006
62. Schaeffer RC, Gong F, Bitrick MS, Smith TL. Thrombin and bradykinin initiate discrete endothelial solute permeability mechanisms. Am. J. Physiol. 264(6 Pt 2), H1798-H1809 (1993
63. Cirino G, Cicala C, Bucci MR, Sorrentino L, Maraganore JM, Stone SR. Thrombin functions as an inflammatory mediator through activation of its receptors. J. Exp. Med. 183(3), 821-827 (1996
64. Razin E, Marx G. Thrombin induceddegranulation of cultured bone-marrow derived mast cells. J. Immunol. 133(6), 3282-3285 (1984
65. Jang AS, Park JS, Lee JH, Park SW, Kim DJ, Park CS. Autologous serum skin test for autoantibodies is associated with airway hyperresponsiveness in patients with asthma. Respiration 74(3) 293-296 (2007
66. Asero R, Madonini E. Bronchial hyperresponsiveness is a common feature in patients with chronic urticaria. J. Investig. Allergol. Clin. Immunol. 16(1) 19-23 (2006
67. Wallaert B, Desreumaux P, Copin MC et al. Immunoreactivity for interleukin 3 and 5 and granulocyte-macrophage colony-stimulating factor of intestinal mucosa in bronchial asthma. J. Exp. Med. 182(6), 1897-1904 (1995
68. Benard A, Desreumeaux P, Huglo D, Hoorelbeke A, Tonnel AB, Wallaert B. Increased intestinal permeability in bronchial asthma. J. Allergy Clin. Immunol. 97(6), 1173-1178 (1996
69. Louis E, Louis R, Drion V et al. Increased frequency of bronchial hyperresponsiveness in patients with inflammatory bowel disease. Allergy 50(9), 729-733 (1995
70. Louis E, Louis R, Shute J et al. Bronchial eosinophilic infiltration in Crohn's disease in the absence of pulmonary disease. Clin. Exp. Allergy 29(5), 660-666 (1999
71. Wen Z, Fiocchi C. Inflammatory bowel disease: autoimmune or immune-mediated pathogenesis? Clin. Dev. Immunol. 11(3-4), 195-204 (2004 (Pubitemid 39423298)
72. Rottem M, Shoenfeld Y. Asthma as a paradigm for autoimmune disease. Int. Arch. Allergy Immunol. 132(3), 210-214 (2003
73. Hanania NA. Targeting airway inflammation in asthma: current and future therapies. Chest 133(4), 989-998 (2008
74. Mullarkey MF, Blumenstein BA, Andrade WP, Bailey GA, Olason I, Wetzel CE. Methotrexate in the treatment of corticosteroid-dependent asthma. A double-blind crossover study. N. Engl. J. Med. 318(10), 603-607 (1988
75. Alexander AG, Barnes NC, Kay AB. Trial of cyclosporin in corticosteroid-dependent chronic severe asthma. Lancet 339(8789), 324-328 (1992
76. Davies H, Olson L, Gibson P. Methotrexate as a steroid sparing agent for asthma in adults. Cochrane Database Syst. Rev. 2, CD000391 (2000
77. Evans DJ, Cullinan P, Geddes DM. Cyclosporin as an oral corticosteroid sparing agent in stable asthma. Cochrane Database Syst. Rev. 2, CD002993 (2001
78. Evans DJ, Cullinan P, Geddes DM. Gold as an oral corticosteroid sparing agent in stable asthma. Cochrane Database Syst. Rev. 2, CD002985 (2001
79. Evans DJ, Cullinan P, Geddes DM. Troleandomycin as an oral corticosteroid steroid sparing agent in stable asthma. Cochrane Database Syst. Rev. 2, CD002987 (2001
80. Milgrom H, Fick RB Jr, Su JQ et al. Treatment of allergic asthma with monoclonal anti-IgE antibody. rhuMAb-E25 Study Group. N. Engl. J. Med. 341(26), 1966-1973 (1999
81. Solèr M, Matz J, Townley R et al. The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics. Eur. Respir. J. 18(2), 254-261 (2001
82. Humbert M, Beasley R, Ayres J et al. Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE. Allergy 60(3), 309-316 (2005
83. Spector SL, Tan RA. Effect of omalizumab on patients with chronic urticaria. Ann. Allergy Asthma Immunol. 99(2), 190-193 (2007
84. Giavina-Bianchi P, Giavina-Bianchi M, Agondi R, Kalil J. Administration of anti-IgE to a Churg-Strauss syndrome patient. Int. Arch. Allergy Immunol. 144(2), 155-158 (2007
85. Leung DY, Sampson HA, Yunginger JW et al.; Avon Longitudinal Study of Parents and Children Study Team. Effect of anti-IgE therapy in patients with peanut allergy. N. Engl. J. Med. 348(11), 986-993 (2003
86. Carter MC, Robyn JA, Bressler PB, Walker JC, Shapiro GG, Metcalfe DD. Omalizumab for the treatment of unprovoked anaphylaxis in patients with systemic mastocytosis. J. Allergy Clin. Immunol. 119(6), 1550-1551 (2007
87. Kontou-Fili K. High omalizumab dose controls recurrent reactions to venom immunotherapy in indolent systemic mastocytosis. Allergy 63(3), 376-378 (2008
88. Caramori G, Groneberg D, Ito K, Casolari P, Adcock IM, Papi A. New drugs targeting Th2 lymphocytes in asthma. J. Occup. Med. Toxicol. 3(Suppl. 1), S6 (2008
89. Berry MA, Hargadon B, Shelley M et al. Evidence of a role of tumor necrosis factor-? in refractory asthma. N. Engl. J. Med. 354(7), 697-708 (2006
90. Brightling C, Berry M, Amrani Y. Targeting TNF-α: a novel therapeutic approach for asthma. J. Allergy Clin. Immunol. 121(1), 5-10 (2008
91. Holgate ST, Holloway J, Wilson S et al. Understanding the pathophysiology of severe asthma to generate new therapeutic opportunities. J. Allergy Clin. Immunol. 117(3), 496-506 (2006